BSX Q2 2021 Earnings — Boston Scientific Corporation Revenue & Financial Results | Market Cap Arena

BSXBoston Scientific Corporation

$103B

Q2 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$3.1B+53.6% YoY

Gross Profit

$1.9B63.1% margin

Operating Income

$511M16.6% margin

Net Income

$186M6.0% margin

EPS (Diluted)

$0.12

QoQ Revenue Growth

+11.8%

Cash Flow

Operating Cash Flow

$643M

Free Cash Flow

$537M

Stock-Based Comp.

$47M

Balance Sheet

Total Assets

$31.2B

Total Liabilities

$15.2B

Stockholders' Equity

$15.9B

Cash & Equivalents

$2.7B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3.1B	$2.0B	+53.6%
Gross Profit	$1.9B	$987M	+96.8%
Operating Income	$511M	-$61M	+937.7%
Net Income	$186M	-$147M	+226.5%

Revenue Segments

Cardiovascular

$1.3B41%

MedSurg

$948M31%

Cardiac Rhythm Management

$866M28%

Geographic Segments

UNITED STATES

$1.8B58%

Non-US

$1.3B42%